Verastem (VSTM) Change in Inventory (2018 - 2026)

Verastem (VSTM) recorded quarterly Change in Inventory of $454000.0 in Q1 2026, up 1064.1% quarter-over-quarter from $39000.0 in Q4 2025.

Verastem (VSTM) Change in Inventory (2018 - 2026) Analysis & Trends

Verastem's Change in Inventory history runs 5 years deep, the most recent figure standing at $454000.0 for Q1 2026.

In Q1 2026, Change in Inventory changed N/A year-over-year to $454000.0; the TTM figure through Mar 2026 stood at $1.1 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, changed N/A from the prior year.
Change in Inventory was $454000.0 for Q1 2026 at Verastem, up from $39000.0 in the prior quarter.
In the past five years, Change in Inventory ranged from a high of $626000.0 in Q3 2025 to a low of $39000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	51,468.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	97.70 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Verastem	407.42 Mn	225.74 Mn	15.90 Mn	454,000.00

Download Data